The pathophysiology of systemic edema
https://doi.org/10.28996/1680-4422-2017-4-438-448
Abstract
About the Authors
A. I. DyadykRussian Federation
T. E. Kugler
Russian Federation
E. V. Schukina
Russian Federation
S. R. Zborovskyy
Russian Federation
Y. V. Suliman
Russian Federation
References
1. Aрутюнов Г.П. Диуретики в повседневной практике. Сердце. 2008. 7 (5): 360-366. Arutyunov G.P. Diuretiki v povsednevnoj praktike. Serdce. 2008. 7 (5): 360-366.
2. Багров Я.Ю., Манусова Н.Б. Генерализованные отеки. Патогенез и лечение (Лекция). Нефрология и диализ. 2011. Т13. №4: 388- 395. Ya.Yu. Bagrov, N.B. Manusova. Generalised edema. Pathogenesis and treatment. (Lecture). Nephrology and dialysis. 2011. 13. 4: 388-395.
3. Дядык А.И. и соавт. Объемы крови у больных хроническим гломерулонефритом. Тер. Архив. 1992. 64 (12): 94-96. Dyadyk A.I. et al. Blood volumes in patients with chronic glomerulonephritis. Ter. Archive. 1992. 64 (12): 94-96. Transl.from Russian.
4. Козловская Л., Бобкова И., Фомин В. Почечные отеки: механизмы развития, принципы лечения. Врач. 2010. 6: 14-17. Kozlovskaya L., Bobkova I., Fomin V. Renal edema: mechanisms of development, principles of treatment. Doctor. 2010. 6: 14-17. Transl.from Russian.
5. Максименко А.В., Тарушев А.Д. Функции и состояние эндотелиального гликокаликса в норме и патологии. Атеросклероз и дислипидемия. 2011. 2: 4-17. Maksimenko A.V., Tarushev A.D. Functions and condition of endothelial glycocalyx in norm and pathology. Atherosclerosis and dyslipidemia. 2011. 2: 4-17. Transl.from Russian.
6. Мухин Н., Фомин В. Отечный синдром: современное понимание проблемы. Врач. 2008. 6: 7-12. Mukhin N., Fomin V. Edema syndrome: modern understanding of the problem. Doctor. 2008. 6: 7-12. Transl.from Russian.
7. Мухин Н.А., Фомин В.В., Пулин А.А. Проблема резистентности к диуретикам: причины и возможные пути решения. Справочник поликлинического врача. 2011; 2:29-32 Mukhin N.A., Fomin V.V., Pulin A.A. The problem of diuretic resistance: causes and possible solutions. Reference book of the polyclinic doctor. 2011; 2: 29-32. Transl.from Russian.
8. Руководство по нефрологии. Под ред. А.И. Дядыка. Е.А. Дядык. К.: Четверта хвиля, 2011. 600 c. Rukovodstvo po nefrologii. Pod red. E.A. Dyadyka. E.A. Dyadyk. K.: Chetverta hvilya, 2011. 600 s.
9. Томилина Н.А. Жилинская Т.Р. Столяревич Е.С. и др. Морфологическая структура поражения почек при сахарном диабете 2-го типа. Нефрология и диализ. 2013. 15 (4): 318-319 Tomilina N.A. Zhilinskaya T.R., Stolyarevich E.S., et al. Morphological structure of kidney desease in diabetes mellitus type 2. Nephrology and dialysis. 2013. 15 (4): 318-319. Transl.from Russian.
10. Alphonsus C., Rodseth R. The endothelial glycocalyx: a review of the vascular barrier. Anaesthesia. 2014. 69(7):777-84.
11. Bekheirnia M.R., Schrier R.W. Pathophysiology of water and soium retention: edematous states with normal kidney function. Curr. Opin. Pharmacol. 2006. 6: 202.
12. Berl T. Vasopressin antagonists. N. Engl. J. Med. 2015. 372 (23): 2207-2216.
13. Besse-Eschmann V., Klisic J., Nief V., et al. Regulation of the proximal tubular sodium/proton exchanger NHE3 in rats with puromycin aminonucleoside (PAN)-induced nephrotic syndrome. J Am Soc Nephrol. 2002. 13: 2199-2206.
14. Birn H. Renal albumin absorbtion in physiology and pathology. Kidn. Int. 2006. 69: 440-49.
15. Bobkova I., Chebotareva N., Kozlovskaya L., Shilov E. Edema in renal diseases - current view on pathogenesis. Nephrology @ Point of Care. 2016. 2(1): 47-55.
16. Bock J.S., Gottlieb S.S. Cardiorenal syndrome: New perspectives. Circulation. 2010. 121: 2592-2600.
17. Brater D.C. Update in diuretic therapy: clinical pharmacology. Sem. Nephrol. 2011. 31(6): 483-494.
18. Braunwald E. Responsiveness to loop diuretics in heart failure. Eur. Heart J. 2014. 35: 1235-1237.
19. Brenner and Rector's the Kidney edited by Karl Skorecki et al. Elsevier; 10 edition, 2016. 2748 pages.
20. Brown EA, Markandu ND, Sagnella GA, et al. Lack of effect of captopril on the sodium retention of the nephrotic syndrome. Nephron. 1984. 37: 43-48.
21. Catena C., Colussi G., Brosolo G. et al. Aldosterone and aldosterone antagonists in cardiac disease: what is know, what is new. Amer. J. Cardiovasc. Dis. 2012. 2 (1): 50-57.
22. Chandra M, Hoyer JR, Lewy JE. Renal function in rats with unilateral proteinuria produced by renal perfusion with aminonucleoside. Pediatr Res. 1981. 15: 340-4.
23. Danziger J., Hoenig M.P. The Role of the Kidney in Disorders of Volume: Core Curriculum 2016. Am J Kidney Dis. 2016. 68 (5): 808-816.
24. Davison D., Basu R.K., Goldstein S.L., Chawla L.S. Fluid management in adults and children: core curriculum. Am J Kidney Dis. 2014. 63(4): 700-712.
25. Deschenes G., Doucet А. Collecting duct (Na+/K+)-ATPase activity is correlated with urinary sodium excretion in rat nephrotic syndromes. J Am Soc Nephrol. 2000. 11: 604-15.
26. Deschenes G., Feraille E., Doucet A. Mechanisms of oedema in nephrotic syndrome: old theories and new ideas. Nephrol. Dial. Transplant. 2003. 18: 454-56.
27. Doucet A., Favre G. et al. Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications. Pediatr Nephrol. 2007. 22(12): 1983-1990.
28. Duffy M., Shashank J., Harrel N. et al. Albumin and furosemide combination for management of edema in nephrotic syndrome: a rewiew of clinical studies Cell. 2015. 4: 622-630.
29. Ellison D.H., Hoorn E.J., Wilcox C.S. Diuretics. Hypertension and the Kidney. 2012. 50: 1879-1916.
30. Hamm L. Edema in the nephrotic syndrome: new aspect of old enigma. J. Am. Soc. Nephrol. 2003. 14: 3288-89.
31. Hamm L. et al. Regulation of sodium transport by ENaC in the kidney. Curr. Opin. Nephrol. Hypertens. 2010. 19 (1): 98-105.
32. Harada K, Izawa H, Nishizawa T, et al. Beneficial effects of torasemide on systolic wall stress and sympathetic nervous activity in asymptomatic or mildly symptomatic patients with heart failure: Comparison with azosemide. J Cardiovasc Pharmacol. 2009. 53: 468-473.
33. Hasenfuss G., Teerlink J. Cardiac inotropes: current agents and future directions. Eur. Heart J. 2011. 32: 1838-45.
34. Ichikawa I, Rennke HG, Hoyer JR, et al. Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest. 1983. 71: 91-103.
35. Iwatsuki S, Popovtzer M.M., Corman J.L., et al. Recovery from “hepatorenal syndrome” after orthotopic liver transplantation. N Engl J Med. 1973. 289: 1155-1159.
36. Juncos L. Intrarenal mechanisms of salt and water retention in the nephritic syndrome. Kidney International. 2002. 61: 1182-1195.
37. Kalra O.P. Amitesh Aggarwal. Rational use of diuretics and pathophysiology of edema. Medicine Update. 2012. 22: 601-610.
38. Klisic J. et al. Albumin regulates the Na+/H+ exchanger 3 in OKP cells. J. Am. Soc. Nephrol. 2003. 14: 3008-16.
39. Koomans H. Pathophysiology of oedema in idiopathic nephrotic syndrome. Neprol. Dial. Transplant. 2003. 18 (6): 30-32.
40. Koomans H.A., Geers A.B., Meiracker A.H., et al. Effects of plasma volume expansion on renal salt handling in patients with the nephrotic syndrome. Am J Nephrol. 1984. 4: 227-34.
41. Koomans HA, Kortlandt W, Geers AB, et al. Lowered protein content of tissue fluid in patients with the nephrotic syndrome: observations during disease and recovery. Nephron 1985. 40: 391-5.
42. Kurtzman N.A. Nephritic edema. Sem. in Nephrology. 2001. 21 (3): 257-261.
43. Melissa A. et al. The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications. Pediatr. Nephrol. 2014. 29: 1159-1167.
44. Min B., White C.M. A review of critical differences among loop, thiazide, and thiazide-like diuretics. Hosp. Pharmacol. 2009. 44 (2): 129-149.
45. Palmer B.F., Alpern R.J., Seldin D.W. Physiology and pathophysiology of sodium retention and wastage. Seldin and Giebisch’s The Kidney Physiology and Pathophysiology; ed. by R.J. Alpern. USA: Elsevier Inc. 2008. 36: 1000 - 1049.
46. Passero C.J. et al. Plasmin activates epithelial Na+ channels by cleaving the gamma subunit. J. Biol Chem. 2008. 26.283(52): 36586-91. doi: 10.1074/jbc.M805676200.
47. Peters J.P. The role of sodium in the production of edema. N.Engl.J.Med. 1948. 239: 353-362.
48. Plant L. Management of the Nephrotic Patient: treatment of ECF Volume Expansion Due to Nephrotic syndrome in adults. Practical Nephrology ed. by Harber M. London. 2014: 165-169.
49. Qavi A.H., Kamal R., Schrier R.W. Clinical use of diuretics in heart failure, cirrhosis and nephrotic syndrome.Int. J. of Nephrology. 2015. 11: 164-167.
50. Rodriguez-Iturbe B., Baggio B., Colina-Chouria J., et al. Studies on the renin-aldosterone system in the acute nephritic syndrome. Kidney Int. 1981. 19: 445-453.
51. Rodriguez-Iturbe B., Colic D., Parra G, et al. Atrial natriuretic factor in the acute nephritic and nephrotic syndromes. Kidney Int. 1990. 38: 512-517.
52. Rondon-Berrios H. New insights into the pathophysiology of oedema in nephrotic syndrome. Nefrologia. 2011. 31(2): 148-154.
53. Schrier R.W. Decreased effective blood volume in edematous disorders; what does this mean? J. Amer. Soc. Nephrol. 2007. 18: 2028-2031.
54. Schrier R.W. Use of diuretics in heart failure and cirrhosis. Seminars in Nephrology. 2011. 31(6): 503-512. doi: 10.1016/j.semnephrol.2011.09.005.
55. Schrier R.W., Ellison D.H. The edematous patient: cardiac failure, cirrhosis, and nephrotic syndrome. Manual of Nephrology; ed. by R.W. Schrier - Philadelphia/USA: Lippincott Williams and Wilkins. 2009. 1: 2-27.
56. Schrier R.W., Fassett R.G. A critique of the overfill hypothesis of sodium and water retention in the nephrotic syndrome. Kidney Int. 1998. 53(5): 1111-1117.
57. Siddall Eric C., Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome. Kidney International. 2012. 82: 635-642. doi:10.1038/ki.2012.180.
58. Singer D.R., Markandu N.D., Buckley M.G., et al. Blood pressure and endocrine responses to changes in dietary sodium intake in cardiac transplant recipients. Circulation. 1994. 89: 1153-1159.
59. Steyl C, Van Zyl-Smit R. Mechanisms of oedema formation: the minor role of hypoalbuminaemia. S Afr Med J. 2009. 99: 57-9.
60. Svenningsen P. et al. Plasmin in nephrotic urine activates the epithelial sodium channel. J Am Soc Nephrol. 2009. 20: 299-310.
61. Turner N. Pathophysiology of oedema in nephrotic syndrome Oxford Textbook of Clinical Nephrology (4 ed.) edited by Neil N. Turner et al. Section 3. Chapter 53. 496-498.
62. Usberti M, Gazzotti R.M. et al. Considerations on the Sodium Retention in Nephrotic syndrome. Am J Nephrol. 1995. 15: 38-47.
63. Usberti M, Gazzotti RM. Hyporeninemic hypoaldosteronism in patients with nephrotic syndrome. Am J Nephrol. 1998. 18: 251-5.
64. Ushiyama A., Kataoka H. Glycocalyx and its involvement in clinical pathophysiologies. Journal of Intensive Care. 2016. 4: 59-70.
65. Van Liew J.B., Noble B., Brentjens J.R. Absence of sodium and water retention in rats with severe proteinuria. Nephron. 1985. 40: 476-481.
66. Vazir A., Cowie M.R. The use of diuretics in acute heart failure: Evidence based therapy? World J. Cardiovasc. Dis. 2013. 3: 25-34.
Review
For citations:
Dyadyk A.I., Kugler T.E., Schukina E.V., Zborovskyy S.R., Suliman Y.V. The pathophysiology of systemic edema. Nephrology and Dialysis. 2017;19(4):438-448. (In Russ.) https://doi.org/10.28996/1680-4422-2017-4-438-448